By Colombian War College December 29, 2016 Major General Juan Carlos Salazar Salazar, president of the Colombian War College (ESDEGUE, per its Spanish acronym), and Brigadier General Jorge Arnoldo Fuentes Hernández, provost of Honduras’s Defense University, signed an academic cooperation agreement between both educational institutions in late November. The agreement was formalized on the principles of alignment and mutual support between the two Latin American countries. The joint effort calls for student and teacher exchanges, sharing scientific research, and other activities of common interest that may allow for the best use of human talent, infrastructure, and teamwork in educational, training, and specialization programs. It also deals with the exchange of information about graduate programs and the development of joint research projects and activities that may contribute to solving their shared national defense and security issues. In the official ceremony, the president of ESDEGUE recalled the transnational realities and threats common to the region, and emphasized the need to join forces to confront them. “No one is able to solve these problems alone. That is why we need each other,” he said. The provost of Honduras’s Defense University celebrated the signing of the cooperation agreement and highlighted the vast experience Colombia has in the field. “We know that accords are needed with other countries that are much more developed than Honduras. That is why this accord with Colombia is needed,” he stated. The mission of Honduras’s Defense University is to provide training and specialization to professionals in the military, aeronautical, and naval sciences, and to develop their leadership, technical, educational and administrative capabilities. It also includes providing them with a solid ethical and moral formation that will allow them to plan the defense of their homeland, the strengthening of their state, and the peace and stability of their democracy. The Colombian War College provides an interdisciplinary educational approach to training military strategy leaders, as well as national and international civilian leaders to face security and defense challenges.
RDIF said it was now set to produce more than 100,000 courses in July and that a joint venture with pharmaceutical firm ChemRar Group would allow it to increase production threefold to meet growing demand both domestically and internationally.Kirill Dmitriev, the head of RDIF, said Russia was ready to help other nations fight the virus and that more than 50 countries had expressed their interest in the drug.There is now no vaccine against COVID-19. The inexpensive anti-inflammatory drug dexamethasone has been shown to reduce the death rate in severe cases, and the anti-viral drug remdesivir has been shown to speed recovery. Nearly all the world’s supply of remdesivir was bought by the United States.Russia said on Thursday it had recorded 6,760 new cases of novel coronavirus infection in the last 24 hours, in line with figures in recent days. That brought its confirmed total to 661,165 cases, the third highest in the world after Brazil and the United States.After imposing a strict lockdown, the authorities have largely lifted restrictions on movement and business, despite thousands of new cases a day. International flights remain banned, however, and RBC business daily reported that this would be extended until Aug. 1. Topics : Russia’s sovereign wealth fund said on Thursday it will step up the production of the anti-viral drug Avifavir, an anti-influenza medicine which the Russian government has granted preliminary approval for treatment of COVID-19 patients.The Russian health ministry gave its approval for the drug’s use under a special accelerated process in May. Its Russian backers say it has shown a benefit in COVID-19 patients in early research.The first 100,000 treatment courses were delivered last month to 35 Russian regions, as well as to neighboring Belarus, said the Russian Direct Investment Fund (RDIF) which has promoted the drug.